focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

1 Nov 2013 10:33

RNS Number : 9870R
China Private Equity Inv Hldgs Ld
01 November 2013
 



 

1 November 2013

 

 

 

China Private Equity Investment Holdings Limited

 

("CPE" or the "Company")

 

Board Appointment

 

China Private Equity Investments Holdings Limited announces that Conor MacNamara has joined the board as a non-executive director with immediate effect.

 

Mr MacNamara is a partner of Adamas Asset Management (formerly Gen2 Partners Limited) ("Adamas") responsible for capital raising for all of their funds, including the Asia /Japan fund of funds and the Asia and Greater China private equity funds. He is an experienced investment banker with significant experience in structuring alternative investment products. Mr MacNamara has spent most of his career in the Japanese and Asian markets, holding senior positions at a number of institutions including ABN Amro / RBS Global Banking, Gen Re Securities and RBC Dominion Securities.

 

Commenting on the appointment of Conor MacNamara, CPE's Executive Chairman, John Croft, said, "We are delighted to welcome Conor to the board of directors of CPE. We look forward to progressing our relationship with Adamas and I believe that the Company will benefit from Conor's experience in the Asian markets as well as his ability to source capital for investment."

 

Disclosures under Schedule 2(g) of AIM Rules for Conor MacNamara are as follows:

 

Full name and age: Conor Michael MacNamara, age 47

 

Current Directorships / Partnerships

Past Directorships / Partnerships within the last five years

Adamas Asia Private Credit Fund

Adamas Asset Management Japan KK (previously Gen2 Partners Limited)

BRJ China Credit Fund Limited

 

KS Asia Absolute Return Fund

There are further no disclosures to be made pursuant to Schedule 2 paragraph (g) of AIM Rules in respect of Conor MacNamara.

 

 

For further information, please visit www.cpe-invest.com or contact:

 

Maria Leung

China Private Equity Investment Holdings Ltd:

 

+852 2801 6770

 

Nominated Adviser & Broker:

Azhic Basirov / Siobhan Sergeant,

Smith & Williamson Corporate Finance Ltd:

 

+44 (0) 20 7131 4000

 

Public Relations Advisers:

Allan Piper

First City Public Relations (Hong Kong):

 

+852 2854 2666

 

Simon Hudson

Tavistock Communications (London):

 

+44 (0) 20 7920 3170

 

www.cpe-invest.com

Ticker symbol:

London - CPEH

Frankfurt - AA1JBE5

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABGBDBDXGBGXB
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.